Viral Hepatitis

You have full text access to this OnlineOpen article

Increased rate of death related to presence of viremia among hepatitis C virus antibody–positive subjects in a community-based cohort study†

  1. Hirofumi Uto1,‡,*,
  2. Sherri O. Stuver2,3,
  3. Katsuhiro Hayashi4,
  4. Kotaro Kumagai1,
  5. Fumisato Sasaki1,
  6. Shuji Kanmura1,
  7. Masatsugu Numata1,
  8. Akihiro Moriuchi1,
  9. Susumu Hasegawa1,
  10. Makoto Oketani1,
  11. Akio Ido1,
  12. Kazunori Kusumoto5,
  13. Satoru Hasuike5,
  14. Kenji Nagata5,
  15. Michinori Kohara6,
  16. Hirohito Tsubouchi1

Article first published online: 1 APR 2009

DOI: 10.1002/hep.23002

Issue

Hepatology

Hepatology

Volume 50, Issue 2, pages 393–399, August 2009

Additional Information

How to Cite

Uto, H., Stuver, S. O., Hayashi, K., Kumagai, K., Sasaki, F., Kanmura, S., Numata, M., Moriuchi, A., Hasegawa, S., Oketani, M., Ido, A., Kusumoto, K., Hasuike, S., Nagata, K., Kohara, M. and Tsubouchi, H. (2009), Increased rate of death related to presence of viremia among hepatitis C virus antibody–positive subjects in a community-based cohort study. Hepatology, 50: 393–399. doi: 10.1002/hep.23002

Author Information

  1. 1

    Department of Digestive and Life-style related Disease, Health Research Human and Environmental Sciences, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima, Japan

  2. 2

    Department of Epidemiology, Boston University School of Public Health, Boston, MA

  3. 3

    Department of Epidemiology, Harvard School of Public Health, Boston, MA

  4. 4

    Center for Medical Education, Faculty of Medicine, University of Miyazaki, Kiyotake, Japan

  5. 5

    Gastroenterology and Hematology, Faculty of Medicine, University of Miyazaki, Kiyotake, Japan

  6. 6

    Department of Microbiology and Cell Biology, Tokyo Metropolitan Institute of Medical Science, Tokyo, Japan

  1. ‡

    fax: (81) 99-264-3504

*Kagoshima University Graduate School of Medical and Dental Sciences, Department of Digestive Disease and Life-style related Disease Health Research, 8-35-1 Sakuragaoka, Kagoshima, Japan 890-8520

  1. †

    Potential conflict of interest: Nothing to report.

Publication History

  1. Issue published online: 29 JUL 2009
  2. Article first published online: 1 APR 2009
  3. Accepted manuscript online: 1 APR 2009 12:00AM EST
  4. Manuscript Accepted: 26 MAR 2009
  5. Manuscript Received: 13 JAN 2009

Funded by

  • United States National Institutes of Health. Grant Number: CA87982
  • Research on Hepatitis and Bovine Spongiform Encephalitis
  • Ministry of Health, Labour and Welfare of Japan
  • Miyazaki Prefecture Collaboration of Regional Entities for the Advancement of Technological Excellence (Japan Science and Technology Corp.)

SEARCH

SEARCH BY CITATION

ARTICLE TOOLS

View Full Article (HTML) Get PDF (153K)

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Masao Omata, Tatsuo Kanda, Ming-Lung Yu, Osamu Yokosuka, Seng-Gee Lim, Wasim Jafri, Ryosuke Tateishi, Saeed S. Hamid, Wan-Long Chuang, Anuchit Chutaputti, Lai Wei, Jose Sollano, Shiv Kumar Sarin, Jia-Horng Kao, Geoffrey W. McCaughan, APASL consensus statements and management algorithms for hepatitis C virus infection, Hepatology International, 2012, 6, 2, 409

    CrossRef

  2. 2
    Lars Haukali Omland, Peter Jepsen, Henrik Krarup, Peer Brehm Christensen, Nina Weis, Lars Nielsen, Niels Obel, Henrik Toft Sørensen, Sherri Oliver Stuver, Liver cancer and non-Hodgkin lymphoma in hepatitis C virus-infected patients: Results from the DANVIR cohort study, International Journal of Cancer, 2012, 130, 10
    Direct Link:
  3. 3
    Liliane Hobeika, Monica Srivastava, Mai Vo, Marie D. Philipneri, David S. Brink, Nadia Wasi, Krista L. Lentine, Lupus-like glomerulonephritis: an autoimmune complication of hepatitis C infection, CEN Case Reports, 2012, 1, 1, 29

    CrossRef

  4. 4
    Bart Grady, Charlotte van den Berg, Jannie van der Helm, Janke Schinkel, Roel Coutinho, Anneke Krol, Maria Prins, No Impact of Hepatitis C Virus Infection on Mortality Among Drug Users During the First Decade After Seroconversion, Clinical Gastroenterology and Hepatology, 2011, 9, 9, 786

    CrossRef

  5. 5
    Eric R. Kallwitz, Ethnic and Racial Differences in the Natural History of Hepatitis C, Current Hepatitis Reports, 2010, 9, 2, 106

    CrossRef

  6. 6
    Tahany Awad, Kristian Thorlund, Goran Hauser, Davor Stimac, Mahasen Mabrouk, Christian Gluud, Peginterferon alpha-2a is associated with higher sustained virological response than peginterferon alfa-2b in chronic hepatitis C: Systematic review of randomized trials, Hepatology, 2010, 51, 4
    Direct Link:
  7. 7
    Ira M. Jacobson, Gary L. Davis, Hashem El–Serag, Francesco Negro, Christian Trépo, Prevalence and Challenges of Liver Diseases in Patients With Chronic Hepatitis C Virus Infection, Clinical Gastroenterology and Hepatology, 2010, 8, 11, 924

    CrossRef

  8. 8
    Changhyun Roh, Ho-Young Lee, Sang-Eun Kim, Sung-Kee Jo, Quantum-dots-based detection of hepatitis C virus (HCV) NS3 using RNA aptamer on chip, Journal of Chemical Technology and Biotechnology, 2010, 85, 8
    Direct Link:
  9. 9
    D. Robert Dufour, Alanine aminotransferase: Is it healthy to be “normal”?, Hepatology, 2009, 50, 6
    Direct Link:
  10. 10
    Elizabeth Kenny-Walsh, Increased liver-related mortality to hepatitis C viremia defined on the 20th anniversary of its identification, Hepatology, 2009, 50, 2
    Direct Link:
View Full Article (HTML) Get PDF (153K)